Creating a database for patients with thrombotic microangiopathies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to construct a comprehensive database for patients diagnosed with thrombotic microangiopathies by collecting detailed clinical data. Patient information will be gathered through the Hitech case system and follow-up via telephone and outpatient visits. The study will include approximately 200 cases and will take place at the First Affiliated Hospital of Soochow University from December 2022 to November 2027, focusing on key clinical indicators such as age, gender, and specific laboratory findings related to the condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The patient has elevated lactate dehydrogenase to more than twice the baseline value, platelets less than 20 or decreased by more than 50% within 24 hours, and more than 2% of schistocytes visible on a peripheral blood smear. Alternatively, pathological sections show extensive micro thrombosis.

Exclusion Criteria:

* The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Where it's running

• The First Affiliated Hospital of Soochow University
  Suzhou, Jiangsu, China Recruiting

Study contacts

• Study coordinator: Yue Han, PhD
• Email: hanyue@suda.edu.cn
• Phone: +86 18913091817

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Role of Interferon and Complement in Second-ary Thrombotic Microangiopathy

  This study tests whether interferon levels relate to the development of TA-TMA in people who have had a transplant or related conditions.

  Recruiting at 3 sites AZ Sint-Jan AV · Ghent, Oost-Vlaanderen and 2 other locations · NCT07705789

• Long-term outcomes for people with immune TTP in the French national TMA cohort

  This project uses past medical records to see long-term health outcomes and complications in people in France who had immune thrombotic thrombocytopenic purpura (iTTP).

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07205861

• Observational study of blood clotting and bleeding disorders in Chinese patients

  This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality and 4 other locations · NCT06727669

• Immunosuppression and caplacizumab with plasma infusion instead of plasma exchange for immune TTP

  This study tests whether adults with immune-mediated TTP can be treated safely and effectively with immunosuppression and caplacizumab plus plasma infusion without daily plasma exchange.

  Recruiting at 24 sites University Hospital, Rouen · Amiens and 29 other locations · NCT06291025

• Identifying blood markers for early diagnosis of transplant-related complications

  This study is trying to find blood markers that can help doctors spot early signs of a serious complication called TA-TMA in patients who have had a stem cell transplant.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT06102694

• Evaluating narsoplimab for treating TMA in children after stem cell transplants

  This study is testing a new treatment called narsoplimab to see if it can help children who are at high risk for blood vessel problems after getting stem cell transplants.

  Recruiting at 4 sites Phase 2 Omeros Corporation · San Diego, California and 15 other locations · NCT05855083

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.